Our expertise spans the entire product development pathway, from OECD safety testing to efficacy substantiation and claim support.

Through partnerships with healthcare institutions and surgical centers, BioToSkin has access to fresh human tissues, with approximately 80% of samples received within 3 hours after surgery. This enables highly relevant ex vivo studies and, when required, the development of in vitro and ex vivo models from the same donor

We also collaborate with aesthetic medicine clinics and integrate clinically used technologies such as lasers, microneedling and energy-based devices into our in vitro and ex vivo models to generate predictive and actionable data.

For companies seeking animal-free development strategies, BioToSkin offers fully VEGAN testing approaches based exclusively on in vitro methods and reconstructed human tissues.